MariMed Inc. provides consulting services for the design, development, operation, funding, and optimization of medical cannabis cultivation, production, and dispensary facilities. The company also develops and manages facilities for the cultivation, production, and dispensing of legal cannabis and cannabis-infused products under the Kalm Fusion brand name. In addition, it offers legal, accounting, human resources, and other corporate and administrative services. As of December 31, 2017, it developed and managed six operating cannabis facilities for clients in Delaware, Illinois, Nevada, and Maryland. MariMed Inc. was incorporated in 2011 and is based in Newton, Massachusetts.
Industry, Sector and Symbol
Industry Packaged Software
Sub-IndustryN/A
SectorTechnology Services
CIKN/A
Phone(844) 244-0200
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees12
Next Earnings DateN/A
OptionableNot Optionable
Marimed (OTCMKTS:MRMD) Frequently Asked Questions
What is Marimed's stock symbol?
Marimed trades on the OTCMKTS under the ticker symbol "MRMD."
How were Marimed's earnings last quarter?
Marimed Inc (OTCMKTS:MRMD) released its quarterly earnings data on Monday, August, 12th. The company reported $0.02 EPS for the quarter. The firm earned $25.67 million during the quarter. View Marimed's Earnings History.
What guidance has Marimed issued on next quarter's earnings?
Marimed updated its third quarter 2019
IntraDay earnings guidance on Monday, November, 25th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $$11.22-11.22 million.
Has Marimed been receiving favorable news coverage?
Media coverage about MRMD stock has been trending somewhat positive this week, according to InfoTrie. The research firm identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Marimed earned a media sentiment score of 2.0 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Marimed.
Who are some of Marimed's key competitors?
What other stocks do shareholders of Marimed own?
Who are Marimed's key executives?
Marimed's management team includes the folowing people:
- Mr. Robert N. Fireman, Pres, CEO & Director (Age 70)
- Mr. Jon R. Levine, CFO, Treasurer, Sec. & Director (Age 54)
- Mr. Tim Shaw, Chief Operating Officer
- Ms. Sara Gullickson, VP of Marketing
- Mr. Ryan Crandall, VP of Product & Sales
How do I buy shares of Marimed?
Shares of MRMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Marimed's stock price today?
One share of MRMD stock can currently be purchased for approximately $0.59.
What is Marimed's official website?
How can I contact Marimed?
The company can be reached via phone at (844) 244-0200.
MarketBeat Community Rating for Marimed (OTCMKTS MRMD)
MarketBeat's community ratings are surveys of what our community members think about Marimed and other stocks. Vote "Outperform" if you believe MRMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MRMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
